MYRIAD - The Salt Lake Tribune News from The Salt Lake Tribune en-us (Webmaster) Myriad’s profits slip but revenues gain ground <div class="hnews hentry item"> <h4><a class="url entry-title" href="">Myriad’s profits slip but revenues gain ground</a></h4> <span class="author source-org vcard"><span class="org fn">The Salt Lake Tribune</span></span> <h5><span class="updated" title="2014-08-13T13:31:41.629-06:00">Updated Aug 13, 2014 01:31PM MDT</span></h5> <div class ="entry-content">Revenues increased but earnings decreased in the fourth quarter for Salt Lake City-based Myriad Genetics, Inc. The molecular-diagnostic company, which discovers and commercializes tests assessing a person’s risk of developing a disease, had a net quarterly income of $37.1 million in the quarter ending June 30, down from $44.1 million a year earlier. That equates to 48 cents per share. Earnings were based on an 8.4 percent increase in revenues, from $174 million to $189. “Myriad had an outstand...</div> <h5><a rel="item-license" href=""> Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> Wed, 13 Aug 2014 13:31:41 MDT